Publications

Title

Author

Year

Estimating the potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study.

CLARK, RA; Portnoy, A; Weerasuriya, CK; SUMNER, T; Bakker, R; Harris, RC; Rade, K; Mattoo, SK; Tumu, D; Menzies, NA; WHITE, RG;

2024

The Lancet regional health - Southeast Asia, (2024).31, 10.1016/j.lansea.2024.100424.

Enhanced Tuberculosis Diagnosis With Computer-aided Chest X-ray and Urine Lipoarabinomannan in Adults With HIV Admitted to Hospital (CASTLE Study): A Cluster Randomized Trial.

BURKE, RM; Nyirenda, SK; Mtenga, T; Twabi, HH; Joekes, E; Walker, NF; Nyirenda, R; Gupta-Wright, A; Nliwasa, M; FIELDING, K; MacPherson, P; CORBETT, EL;

2024

Clinical Infectious Diseases, (2024).80 5 10.1093/cid/ciae273.

Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis.

Khan, MF; Ali, A; Rehman, HM; Noor Khan, S; Hammad, HM; Waseem, M; Wu, Y; CLARK, TG; Jabbar, A;

2024

Scientific reports, (2024).14 1 10.1038/s41598-024-61752-6.

Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis.

Kho, S; Seung, KJ; Huerga, H; Bastard, M; KHAN, PY; Mitnick, CD; Rich, ML; Islam, S; Zhizhilashvili, D; Yeghiazaryan, L; Nikolenko, EN; Zarli, K; Adnan, S; Salahuddin, N; Ahmed, S; Vargas, ZH R; Bekele, A; Shaimerdenova, A; Tamirat, M; Gelin, A; Vilbrun, SC; Hewison, C; Khan, U; Franke, M;

2024

Nature communications, (2024).15 1 10.1038/s41467-024-48077-8.

The Effect of HIV on the Association of Hyperglycaemia and Active Tuberculosis in Zambia, a Case-Control Study.

Bailey, SL; FLOYD, S; Cheeba-Lengwe, M; Maluzi, K; Chiwele-Kangololo, K; Kaluba-Milimo, D; Amofa-Sekyi, M; Yudkin, JS; Godfrey-Faussett, P; AYLES, H;

2024

Journal of epidemiology and global health, (2024).14 3 10.1007/s44197-024-00236-2.

A novel regulatory interplay between atypical B12 riboswitches and uORF translation in Mycobacterium tuberculosis.

KIPKORIR, T; Polgar, P; Barker, D; D'Halluin, A; Patel, Z; Arnvig, KB;

2024

Nucleic Acids Research (NAR), (2024).52 13 10.1093/nar/gkae338.

Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis.

James, LP; Klaassen, F; SWEENEY, S; Furin, J; Franke, MF; Yaesoubi, R; Chesov, D; Ciobanu, N; Codreanu, A; Crudu, V; Cohen, T; Menzies, NA;

2024

PLoS medicine, (2024).21 5 10.1371/journal.pmed.1004401.

Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization.

Shattock, AJ; JOHNSON, HC; Sim, SY; Carter, A; Lambach, P; Hutubessy, RC W; Thompson, KM; Badizadegan, K; Lambert, B; Ferrari, MJ; JIT, M; FU, H; Silal, SP; Hounsell, RA; WHITE, RG; Mosser, JF; Gaythorpe, KA M; Trotter, CL; Lindstrand, A; O'Brien, KL; Bar-Zeev, N;

2024

Lancet (London, England), (2024).403 10441 10.1016/S0140-6736(24)00850-X.

Integrating molecular and radiological screening tools during community-based active case-finding for tuberculosis and COVID-19 in southern Africa.

Scott, AJ; Limbada, M; Perumal, T; Jaumdally, S; Kotze, A; Van der Merwe, C; Cheeba, M; Milimo, D; Murphy, K; Van Ginneken, B; De Kock, M; Warren, RM; Gina, P; Swanepoel, J; Kühn, L; Oelofse, S; Pooran, A; Esmail, A; AYLES, H; DHEDA, K;

2024

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, (2024).145, 10.1016/j.ijid.2024.107081.

Bridging the gap: evaluating high TB burden country data needs to support the potential introduction of TB vaccines for adolescents and adults: a workshop report.

CLARK, RA; Young, C; Palmer, S; Auma, E; Malhotra, S; Limaye, R; Giersing, B; Schrager, L; Voss, G; Tiemersma, E; Frick, M; Edoka, I; Dagnew, AF; Nkhoma, T; Pelzer, PT; WHITE, RG;

2024

Frontiers in Tuberculosis, (2024).2, 10.3389/ftubr.2024.1384036.